GILD vs NVS
Gilead Sciences Inc (GILD) versus NVS (NVS) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
NVS (NVS) common stock.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
NVS does not have a complete income-statement cache yet.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. NVS currently screens at market cap $0.
Not investment advice. Open the GILD and NVS stock pages for the full models.
Not investment advice.